Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Inhibrx, Inc. (INBX)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 47,380,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Inhibrx is a clinical-stage biotechnology company with a pipeline of novel biologic therapeutic candidates, developed using protein engineering and Co.'s proprietary single domain antibody, or sdAb, platform. Co. has four programs in ongoing Phase 1 clinical trials, three for the treatment of various cancers, and one for Alpha-1 Antitrypsin Deficiency. Co.'s most advanced therapeutic candidate, INBRX-109, is a tetravalent death receptor 5, or DR5, agonist being evaluated in patients diagnosed with chondrosarcoma and mesotheliom. INBRX-106 is a hexavalent OX40 agonist developed for patients with locally advanced or metastatic solid tumors. Co. is also developing INBRX-105 and INNBRX-101.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 511,627 1,844,960
Total Buy Value $0 $0 $9,899,982 $49,899,839
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 2
Total Shares Sold 0 0 0 502,060
Total Sell Value $0 $0 $0 $12,346,854
Total People Sold 0 0 0 3
Total Sell Transactions 0 0 0 22
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 51
  Page 1 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Shabet Rose Sharon   •       •       •   2023-08-28 4 B $19.35 $9,899,982 I/I 511,627 511,627 0.01     -
   Eckelman Living Trust Dated February 5, 2014 10% Owner   –       –       •   2023-03-01 4 AS $24.20 $968,231 I/I (40,000) 2,035,553     -
   Lappe Family Trust To be Verified   –       –      –    2023-02-28 4 AS $25.02 $1,501 I/I (60) 2,486,192     -
   Eckelman Living Trust Dated February 5, 2014 10% Owner   –       –       •   2023-02-02 4 AS $25.40 $286,355 I/I (11,250) 2,075,553     -
   Eckelman Living Trust Dated February 5, 2014 10% Owner   –       –       •   2023-02-01 4 AS $24.29 $710,856 I/I (28,750) 2,086,803     -
   Lappe Family Trust To be Verified   –       –      –    2023-01-24 4 AS $25.71 $111,478 I/I (4,335) 2,486,252     -
   Lappe Family Trust To be Verified   –       –      –    2023-01-23 4 AS $25.36 $549,364 I/I (21,665) 2,490,587     -
   Kayyem Jon Faiz Director   –       •      –    2023-01-23 4 AS $25.26 $239,999 I/I (9,500) 3,224,301     -
   Eckelman Living Trust Dated February 5, 2014 10% Owner   –       –       •   2023-01-04 4 AS $23.11 $166,829 I/I (7,105) 2,115,553     -
   Eckelman Living Trust Dated February 5, 2014 10% Owner   –       –       •   2023-01-03 4 AS $23.41 $781,770 I/I (32,895) 2,122,658     -
   Kayyem Jon Faiz Director   –       •      –    2022-12-21 4 AS $26.87 $256,679 I/I (9,500) 3,233,801     -
   Lappe Family Trust To be Verified   –       –      –    2022-12-19 4 AS $25.53 $664,443 I/I (26,000) 2,512,252     -
   Eckelman Living Trust Dated February 5, 2014 10% Owner   –       –       •   2022-12-06 4 AS $26.83 $1,088,683 I/I (40,000) 2,155,553     -
   Kayyem Jon Faiz Director   –       •      –    2022-11-21 4 AS $29.33 $283,972 I/I (9,500) 3,243,301     -
   Lappe Family Trust To be Verified   –       –      –    2022-11-17 4 AS $25.36 $724,910 I/I (26,000) 2,538,252     -
   Eckelman Living Trust Dated February 5, 2014 10% Owner   –       –       •   2022-11-01 4 AS $33.34 $1,340,387 I/I (40,000) 2,195,553     -
   Kayyem Jon Faiz Director   –       •      –    2022-10-21 4 AS $29.39 $286,232 I/I (9,500) 3,252,801     -
   Lappe Family Trust To be Verified   –       –      –    2022-10-17 4 AS $28.66 $769,443 I/I (26,000) 2,564,252     -
   Shabet Rose Sharon   •       •       •   2022-10-07 4 B $30.00 $39,999,857 I/I 1,333,333 333,333 0.01     -
   Eckelman Living Trust Dated February 5, 2014 10% Owner   –       –       •   2022-10-04 4 AS $24.67 $1,112,813 I/I (40,000) 2,235,553     -
   Eckelman Living Trust Dated February 5, 2014 10% Owner   –       –       •   2022-09-13 4 GA $0.00 $0 I/I 160,000 160,000     -
   Eckelman Living Trust Dated February 5, 2014 10% Owner   –       –       •   2022-09-13 4 GD $0.00 $0 I/I 160,000 2,275,553     -
   Eckelman Living Trust Dated February 5, 2014 10% Owner   –       –       •   2022-09-06 4 AS $14.86 $596,274 I/I (40,000) 2,435,553     -
   Kayyem Jon Faiz Director   –       •      –    2022-08-24 4 GD $0.00 $0 I/I 11,900 3,262,301     -
   Kayyem Jon Faiz Director   –       •      –    2022-08-05 4 GD $0.00 $0 I/I 3,400 3,274,201     -

  51 Records found
  1  2  3   
  Page 1 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed